Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Nature Communications|March 5, 2022
Waning of SARS-CoV-2 booster viral-load reduction effectivenessMatan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.Molecular Cell|March 23, 2011
The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBKMaria Belitsky, Haim Avshalom, Ariel Erental, et al.Nature Medicine|July 6, 2019
Personal clinical history predicts antibiotic resistance of urinary tract infectionsIdan Yelin, Olga Snitser, Gal Novich, et al.Nature Communications|April 26, 2020
Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitorDor Russ, Fabian Glaser, Einat Shaer Tamar, et al.Nature Medicine|November 3, 2021
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.Nature Medicine|June 11, 2021
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individualsOren Milman, Idan Yelin, Noga Aharony, et al.The Journal of Molecular Diagnostics : JMD|November 26, 2021
SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since DiagnosisMatan Levine-Tiefenbrun, Idan Yelin, Hedva Uriel, et al.Science (New York, N.Y.)|February 24, 2022
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infectionsMathew Stracy, Olga Snitser, Idan Yelin, et al.Nature Medicine|March 30, 2021
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccineMatan Levine-Tiefenbrun, Idan Yelin, Rachel Katz, et al.Nature Medicine|November 9, 2019
Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patientsIdan Yelin, Kelly B Flett, Christina Merakou, et al.Pageof 3